Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
about
A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy.Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.
P2860
Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@en
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@nl
type
label
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@en
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@nl
prefLabel
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@en
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@nl
P2093
P1476
Synchronous Metastatic Clear-C ...... ical, and Molecular Phenotype.
@en
P2093
Adelaide Pladys
Alexandra Lespagnol
Angelique Brunot
Benoit Peyronnet
Brigitte Laguerre
Frederic Dugay
Gregory Verhoest
Guillaume Bouzille
Jean Mosser
Julien Dagher
P356
10.1016/J.CLGC.2016.06.007
P407
P577
2016-06-27T00:00:00Z